1. The clinical practice and dosimetric outcome of the manual adaptive planning during definitive radiotherapy for cervical cancer

   • Yi-Wei Wang
   • Min Chen
   • Hao-Ping Xu

   Research Open access 27 May 2024 Article: 280

   

2. Treatment of endometrial cancer from 2000 to 2020 in Germany: a retrospective population based cohort study

   • Thomas Papathemelis
   • Olaf Ortmann
   • Soo-Zin Kim-Wanner

   Research Open access 27 May 2024 Article: 279

   

3. Prognostic impact and immunotherapeutic implications of NETosis-related prognostic model in clear cell renal cell carcinoma

   • Xingjun Mao
   • Wen Huang
   • Xiaolei Zhang

   Research Open access 27 May 2024 Article: 278

   

4. Nomograms based on ratio indexes to predict severity and prognosis in immune checkpoint inhibitors-related myocarditis: a retrospective analysis

   • Zhenli Li
   • Tiezhu Yao
   • Jingtao Ma

   Research Open access 27 May 2024 Article: 277

   

5. Upregulated lncRNA LINC01128 in colorectal cancer accelerates cell growth and predicts malignant prognosis through sponging miR-363-3p

   • Xiaohu Zhou
   • Yanhui Li
   • Xiaoliang Wu

   Research Open access 26 May 2024 Article: 276

   

6. Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockade

   • Miriam Mengoni
   • Andreas Dominik Braun
   • Alexey Surov

   Research Open access 25 May 2024 Article: 275

   

7. Fluorescein-guided surgery in high-grade gliomas: focusing on the eloquent and deep-seated areas

   • Yao Xiao
   • Mingrui Li
   • Qing Liu

   Research Open access 25 May 2024 Article: 274

   

8. Study on carotid artery stenosis after radiotherapy for nasopharyngeal carcinoma

   • JunMei Song
   • Luo Lan
   • RenSheng Wang

   Research Open access 25 May 2024 Article: 273

   

9. Outcome prediction of SSTR-RADS-3A and SSTR-RADS-3B lesions in patients with neuroendocrine tumors based on ⁶⁸Ga-DOTATATE PET/MR

   • Jing Gao
   • Jinxin Zhou
   • Yifan Zhang

   Research Open access 25 May 2024 Article: 272

   

10. The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort

    • Xiaobing Li
    • De Wu
    • Yuebing Wu

    Research Open access 23 May 2024 Article: 271

    

11. Combined hepatocellular-cholangiocarcinoma: from genesis to molecular pathways and therapeutic strategies

    • Simona Gurzu
    • Rita Szodorai
    • Laura Banias

    Review Open access 23 May 2024 Article: 270

    

12. A novel subtype based on driver methylation–transcription in lung adenocarcinoma

    • Xin Wang
    • Zhenyi Xu
    • Yan Hou

    Research Open access 22 May 2024 Article: 269

    

13. Use superb microvascular imaging to diagnose and predict metastatic cervical lymph nodes in patients with papillary thyroid carcinoma

    • Ting Huang
    • Pin-Tong Huang
    • Yu-Rong Hong

    Research Open access 21 May 2024 Article: 268

    

14. Primary Ewing’s sarcoma of the uterine cervix: a case report and review of the literature

    • Yuhang Xiao
    • Yong Zhi
    • Fang Li

    Case Based Report Open access 21 May 2024 Article: 267

    

15. Target trial emulation of carfilzomib safety among patients with relapsed/refractory multiple myeloma using a nationwide observational data in Korea

    • Hyun Kyung Lee
    • Ha Young Jang
    • Jung Mi Oh

    Research Open access 20 May 2024 Article: 266

    

16. Clinical significance of ¹⁸F-FDG-PET/CT for detection of incidental pre-malignant and malignant colonic lesions: correlation with colonoscopic and histopathological results

    • Yingying Zhang
    • Jiangqin Han
    • Yi Yang

    Research Open access 20 May 2024 Article: 265

    

17. Machine learning identifies the role of SMAD6 in the prognosis and drug susceptibility in bladder cancer

    • Ziang Chen
    • Yuxi Ou
    • Shenghua Liu

    Research Open access 20 May 2024 Article: 264

    

18. A novel tRNA-derived fragment tRF-17-18VBY9M works as a potential diagnostic biomarker for gastric cancer

    • Chunyan Mao
    • Zhihan Zhang
    • Hui Cong

    Research Open access 20 May 2024 Article: 263

    

19. Tumor infiltrating B lymphocytes (TIBs) associate with poor clinical outcomes, unfavorable therapeutic benefit and immunosuppressive context in metastatic clear cell renal cell carcinoma (mccRCC) patients treated with anti-PD-1 antibody plus Axitinib

    • Zhiyuan Lin
    • Shuxiu Xiao
    • Lili Lu

    Research Open access 19 May 2024 Article: 262

    

20. Genome-wide investigation of lncRNAs revealed their tight association with gastric cancer

    • Tong Liu
    • Yuedong Ma
    • Pengda Sun

    Research Open access 18 May 2024 Article: 261

    

21. Survival outcomes of neoadjuvant immunochemotherapy versus chemotherapy for locally advanced esophageal squamous cell carcinoma

    • Huilai Lv
    • Fan Zhang
    • Ziqiang Tian

    Research Open access 17 May 2024 Article: 260

    

22. The emerging role and mechanism of HMGA2 in breast cancer

    • Qing Ma
    • Sisi Ye
    • Wei Zhang

    Review Open access 16 May 2024 Article: 259

    

23. Risk assessment model based on nucleotide metabolism-related genes highlights SLC27A2 as a potential therapeutic target in breast cancer

    • Bo Zhang
    • Yunjiao Zhang
    • Rui Ling

    Research Open access 16 May 2024 Article: 258

    

24. Evaluating the effects of various ethanolic medicinal plant extracts on metastatic breast cancer proliferation, invasion, and expression of a novel potential drug target; CD82 metastatic suppressor protein, and on in vivo angiogenesis using the ex ovo yolk sac membrane (YSM) assay

    • Samantha Loggenberg
    • Danielle Twilley
    • Namrita Lall

    Research Open access 16 May 2024 Article: 257

    

25. Clinicopathologic features and genomic profiling of female axillary lymph node metastases from adenocarcinoma or poorly differentiated carcinoma of unknown primary

    • Liansha Tang
    • Yueting Zhu
    • Jiyan Liu

    Research Open access 15 May 2024 Article: 256

    

26. Construction of a prognostic model for extensive-stage small cell lung cancer patients undergoing immune therapy in northernmost China and prediction of treatment efficacy based on response status at different time points

    • Junjie Dang
    • Gang Xu
    • Lihua Shang

    Research Open access 15 May 2024 Article: 255

    

27. A meta-analysis of MRI radiomics-based diagnosis for BI-RADS 4 breast lesions

    • Jie Lin
    • Hao Zheng
    • Min Ge

    Research Open access 15 May 2024 Article: 254

    

28. Utilizing a structure-based virtual screening approach to discover potential LSD1 inhibitors

    • Zhehao Fan
    • Xiaofeng Liu
    • Haibo Sun

    Research Open access 15 May 2024 Article: 253

    

29. Preferences of physicians for treatment-related toxicity vs. recurrence in melanoma (GERMELATOX-A): the doctors’ perspective

    • Katharina C. Kähler
    • Ralf Gutzmer
    • Christine Blome

    Research Open access 14 May 2024 Article: 252

    

30. FIGO 2023 endometrial staging: a leap of faith into the new “prognostic based’ rather than “anatomical based” staging—too fast too furious??

    • Karthik Chandra Bassetty
    • Dimpy Begum
    • P. S. Roy

    Research Open access 11 May 2024 Article: 251

    

31. Implementation of quality indicators for vulvar cancer in gynaecological cancer centres certified by the German Cancer Society (DKG)

    • Frederik A. Stuebs
    • Matthias W. Beckmann
    • Simone Wesselmann

    Research Open access 10 May 2024 Article: 250

    

32. Psychosocial factors associated with quality of life in cancer survivors: umbrella review

    • Viktorya Voskanyan
    • Chiara Marzorati
    • Gabriella Pravettoni

    Review Open access 10 May 2024 Article: 249

    

33. Endoscopic submucosal dissection versus surgery for T1b esophageal carcinoma: a single-center retrospective study

    • Ting Zhang
    • Hanying Wang
    • Qide Zhang

    Research Open access 09 May 2024 Article: 248

    

34. Prognosis of patients with advanced bile tract carcinoma: assessment using the modified-Gustave Roussy Immune Score (mGRIm-s) as a clinico-immunological tool

    • Yue Ma
    • Yuting Pan
    • Guanghai Dai

    Research Open access 09 May 2024 Article: 247

    

35. Comprehensive molecular analyses of cuproptosis-related genes with regard to prognosis, immune landscape, and response to immune checkpoint blockers in lung adenocarcinoma

    • Ruixia Li
    • Run Tong
    • Gang Hou

    Research Open access 09 May 2024 Article: 246

    

36. RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma

    • Kai You
    • Xingxing Du
    • Huitao Fan

    Research Open access 09 May 2024 Article: 245

    

37. Cystatin SA attenuates gastric cancer cells growth and increases sensitivity to oxaliplatin via PI3K/AKT signaling pathway

    • Yida Lu
    • Huizhen Wang
    • Yongxiang Li

    Research Open access 08 May 2024 Article: 244

    

38. Role played by MDSC in colitis-associated colorectal cancer and potential therapeutic strategies

    • Kang Wang
    • Yun Wang
    • Kai Yin

    Review Open access 08 May 2024 Article: 243

    

39. LAMP2A regulates cisplatin resistance in colorectal cancer through mediating autophagy

    • Zhiliang Shi
    • Shuting Yang
    • Guoqiang Zhou

    Research Open access 08 May 2024 Article: 242

    

40. GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation

    • Wenying Qiao
    • Jiashuo Li
    • Caixia Hu

    Research Open access 07 May 2024 Article: 241

    

41. Identification of immunogenic cell death-related damage-related molecular patterns (DAMPs) to predict outcomes in patients with head and neck squamous cell carcinoma

    • Jiayi Zhang
    • Xinzhan Shi
    • Laikui Liu

    Research Open access 07 May 2024 Article: 240

    

42. KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway

    • Meng Zhai
    • Jiyu Miao
    • Ju Bai

    Research Open access 07 May 2024 Article: 239

    

43. The role of tumor-associated macrophages in tumor immune evasion

    • Ruizhe Huang
    • Ting Kang
    • Siyu Chen

    Review Open access 07 May 2024 Article: 238

    

44. BiSpec Pairwise AI: guiding the selection of bispecific antibody target combinations with pairwise learning and GPT augmentation

    • Xin Zhang
    • Huiyu Wang
    • Chunyun Sun

    Research Open access 07 May 2024 Article: 237

    

45. Total hysterectomy versus radical hysterectomy in neuroendocrine cervical cancer: a SEER-database analysis

    • Feitianzhi Zeng
    • Peng Guo
    • Mian He

    Research Open access 06 May 2024 Article: 236

    

46. Safety, efficacy, and survival of different transarterial chemoembolization techniques in the management of unresectable hepatocellular carcinoma: a comparative single-center analysis

    • Philipp Schindler
    • Daniel Kaldewey
    • Max Masthoff

    Research Open access 06 May 2024 Article: 235

    

47. Modified Lichong decoction intervenes in colorectal cancer by modulating the intestinal flora and the Wnt/β-catenin signaling pathway

    • Longhui Liu
    • Mengmeng Zhao
    • Jianping Liu

    Research Open access 06 May 2024 Article: 234

    

48. Evaluating the clinical efficacy and safety of concurrent chemoradiotherapy with cisplatin and nab-paclitaxel in postoperative early-stage cervical cancer

    • Ning Zhao
    • Yunhai Li
    • Yunhai Li

    Research Open access 06 May 2024 Article: 233

    

49. Effects of concurrent chemoradiotherapy with or without Endostar on the regression of retropharyngeal lymph node and prognosis of patients with locally advanced nasopharyngeal carcinoma: a retrospective study

    • Jun-Mei Song
    • Ning Mo
    • Ting-Ting Zhang

    Research Open access 04 May 2024 Article: 232

    

50. Targeting BMAL1 reverses drug resistance of acute myeloid leukemia cells and promotes ferroptosis through HMGB1-GPX4 signaling pathway

    • Hong Zheng
    • Ting Wu
    • Minghua Yang

    Research Open access 04 May 2024 Article: 231